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A B S T R A C T
The increase of antibiotic-resistant bacteria is growing every day, most likely associated with the indiscriminate
use of these antimicrobials or even with evolutionary adaptability of bacteria to their environment. This si-
tuation brings a need to develop new alternatives to conventional antibiotics, and thus the application of strictly
lytic bacteriophages has been proposed as an alternative (or complement) to the former, allowing release of the
natural predators of bacteria directly where they are needed the most: the infection site. The main advantages of
bacteriophages to treat infections is the maintenance of a high concentration of bacteriophage particles in the
action site while any viable target bacteria still exist, coupled to the production of enzymes that hydrolyze the
polymeric matrix of bacterial bioﬁlms promoting penetration and antibacterial action. In the research eﬀort
entertained herein, the potential for protection and stabilization of strictly lytic bacteriophages with broad
spectrum capable of infecting Pseudomonas aeruginosa, so as to maintain their structure and functionality, was
investigated via encapsulation within the aqueous-core of lipid nanodroplets integrating a W/O/W multiple
emulsion system, aiming at developing isotonic derivative solutions thereof for administration by nebulization.
1. Introduction
The increasing worldwide awareness related to the appearance of
multiple bacterial resistance to conventional chemical antibiotics [1,2]
has shed a renewed interest from the scientiﬁc community to bacter-
iophage (or phage) particles, with these inert (i.e., devoid of any me-
tabolic machinery) entities being re-discovered as high-potential can-
didates for biopharmaceutical (antimicrobial) applications [3–7].
However, like most biological (macro)molecules, phage particles are
intrinsically fragile and therefore their full structural and functional
stabilization is mandatory [3,4,8–11] prior to any use. Solubilization of
these protein-like entities in the aqueous-core of lipid nanodroplets,
protecting them from deactivation by the immune system, dilution ef-
fects, and from any chemical stress [12–15], will thus promote their
structural and functional stabilization [3,4,9,10], a sine qua non con-
dition for these particles to be used as (bio)medicines. Colloidal systems
such as water-in-oil-in-water (W/O/W) multiple emulsions (MEs) are
systems in which dispersions of small water droplets within larger oil
droplets are themselves dispersed in a continuous (external) aqueous
phase [8,10,16–22]. The smaller the sizes of the aqueous-core lipid
nanodroplets the longer their retention times [23,24], and hence such
(lytic) phage-encasing nanodroplets could be utilized, e.g. in the for-
mulation of isotonic aerosols to eliminate bacterial pneumonia caused
by Pseudomonas aeruginosa with one clear advantage: the adhesion of
these lipid nanodroplets to the pulmonary mucosa could slowly liberate
their bacterial predatory content, reducing both the need for chemical
antibiotics and infection elimination time. P. aeruginosa is the second
pathogen causing nosocomial pneumonia [25,26]. Worldwide, it is
found that the antimicrobial resistance rate for P. aeruginosa has in-
creased dramatically [27–30]. Quite recently, a newly developed na-
nocontainment technique for stabilization of protein entities has started
to gain momentum [8,10,31–35]. Entropic conﬁnement (physical en-
trapment) of macromolecular (protein-like) entities such as phage
particles within the aqueous core of these lipid nanodroplets, changes
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the water activity in their microneighborhood while reducing mole-
cular motions [9], leading to increased viscosity [9,34,36]. Lipid na-
nodroplets integrating a W/O/WME are composed of a (physiologically
compatible) lipid matrix [8,10,31,32,37,38], stabilized by emulsiﬁers
such as phospholipids and/or polyoxyethylene ethers
[8,10,16,31,32,39]. When producing a W/O/W ME system, the lipid
concentration required to produce the lipid nanodroplets must be kept
at low levels, since high lipid concentrations further enhance the
thermodynamic instability of these systems and may even promote
their rupture (following release of the inner aqueous core under shear
rate, with concomitant expulsion of the water-soluble protein entities
through the oily layer between both water phases) [16,40,41]. In the
research eﬀort entertained herein, a stable W/O/W ME system was
produced according to the procedure described by Glasser et al. [8,31],
integrating small-sized lipid nanodroplets with aqueous cores housing
phage particles; such phage-encasing W/O/W ME was then used for
developing an isotonic system aiming at the administration via neb-
ulization for the inhalation of lytic (endotoxin-free) phages for the
treatment of pulmonary infection by P. aeruginosa. Hence, the natural
predators of bacteria responsible for provoking lung infections would
be released directly where they are needed the most: the site of infec-
tion.
2. Materials and methods
2.1. Materials
2.1.1. Biological materials
Bacteriophage: Bacteriophage JG004 (ref. DSM 19871) was pur-
chased from Leibniz-Institute DSMZ (Braunschweig, Germany).
Bacterial host: Phage JG004 was propagated in a Pseudomonas aerugi-
nosa host (ref. DSM 19880), acquired from DSMZ. Cell lines: The cell
lines were purchased from BCRJ (Duque de Caxias/RJ, Brazil): cell line
V79-4 (BCRJ code 0244; Chinese Hamster, Lung-Normal); cell line
A549 (BCRJ code 0033; Human, Caucasian, Lung-Carcinoma), and cell
line 3T3 (BCRJ code 0017; Mus musculus (Swiss albino), Fibroblast/
Embrio). Dulbecco’s Modiﬁed Eagle’s Medium (DMEM) was from Gibco
Life Technologies (Alto de Pinheiros, São Paulo/SP, Brazil). The Tali®
Apoptosis Kit (consisting of Annexin V Alexa Fluor® 488 and Propidium
Iodide) was purchased from Invitrogen (Carlsbad CA, U.S.A.).
2.1.2. Chemicals
Lipids: Softisan100™ was a kind gift from Sasol (Sasol
Oleﬁns & Surfactants GmbH, Hamburg, Germany) and glycerol was
from Fluka (Steinheim, Germany). Surfactants: Tween 80 was from
Sigma-Aldrich (St. Louis MO, USA). Kolliphor P188™ (poloxamer 188)
was a kind gift from BASF ChemTrade GmbH (Ludwigshafen,
Germany). Soybean phosphatidylcholine (lecithin) was from Alamar
Tecno-Cientíﬁca Ltda (Diadema/SP, Brazil). Other chemicals:
Commercial HCl (37%, w/w) was from ECIBRA Analytical Reagents
(Curitiba/PR, Brazil). Anhydrous Na2HPO4, NaH2PO4, CaCl2 and NaCl
were from Dinâmica Ltda (Diadema/SP, Brazil). Luria Bertani Broth
(Miller, LB-Broth) was from HiMedia Laboratories Pvt. Ltd (Mumbai,
India) and solid agar was from Gibco Diagnostics (Madison WI, U.S.A.).
The sterilizing ﬁltration system (Stericup™-GP, polyethersulphate (PES)
membrane with 0.22 μm pore diameter) was a kind gift from Merck-
Millipore (Darmstadt, Germany). Nipagin™ (methylparaben) and
MgSO4 were from Labsynth (Diadema/SP, Brazil). Tap water was pur-
iﬁed in a Milli-Q Plus 185 system (Molsheim, France) to a ﬁnal con-
ductivity of ca. 18.2 MΩ.cm−1. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) and DMSO were from Sigma-Aldrich (St.
Louis MO, U.S.A.).
2.1.3. Analytical equipment
Zeta Potential (ZP), Hydrodynamic Size (HS) and Polydispersity
Index (PI) were determined in a ZetaPALS system (model NanoBrook
90PlusPALS from Brookhaven Instruments, Holtsville NY, U.S.A.). FTIR
spectra were gathered in a Fourier Transform Infrared
Spectrophotometer from AGILENT (model Cary 630, Santa Clara CA,
U.S.A.). X-ray diﬀractograms were gathered in an X-ray Diﬀractometer
(XRD) from Shimadzu (model XRD7000, Kyoto, Japan). Nanoparticle
Tracking Analyses (NTA) were carried out in a NanoSight device from
Malvern Instruments Ltd (model LM14C, Worcestershire, United
Kingdom), with NTA software (NanoSight version 3.1). The UV–vis
Spectrophotometer was from Perkin Elmer (model Lambda 3s, Waltham
MA, U.S.A). TGA analyses were carried out using a thermogravimeter
from TA Instruments (model 2050, New Castle, U.S.A.), whereas DSC
analyses were carried out using a diﬀerential scanning micro-
calorimeter from TA Instruments (model MDSC 2910, New Castle,
U.S.A.). TEM analyses were carried out in a Transmission Electron
Microscope from JEOL (model JEM-1400Plus, JEOL, Tokyo, Japan),
equipped with a lanthanum hexaboride (LaB6) ﬁlament, operating at
120 kV, and a high-resolution CCD camera from GATAN Inc. (model
MultiScan 794, Pleasanton CA, U.S.A.) with a resolution of 1k x 1k
pixels for the acquisition of digital images. Cell viability readings via
the MTT assays were carried out in an ELISA microplate reader from
Robonik India Private Ltd. (model Readwell PLATE, Maharashtra,
India). All optical microscopy analyses for the Comet™ assays were
carried out in a Zeiss Axiovert-60 optical microscope (Carl-Zeiss,
Göschwitzer Str., Jena, Germany).
2.2. Experimental procedures
2.2.1. Propagation and puriﬁcation of bacteriophage JG004
The phage (JG004, ref. DSM 19871) was propagated using a speciﬁc
host microorganism, namely P. aeruginosa (ref. DSM 19880), grown in
LB molten agar.
Preparation of a bacterial suspension of P. aeruginosa. The
lyophilized pellet was dissolved in 4.5 mL of Luria-Bertani Broth with
the aid of a sterile loop, and 1 mL of the resulting suspension was plated
on the surface of LB solid medium in Petri plates, which were then
incubated during 24 h at 37 °C. For preparation of a suitable bacterial
suspension, a single CFU was inoculated in a test tube containing 5 mL
sterile LB-broth which was then incubated at 37 °C during 18 h.
Propagation of the bacteriophage. For propagation of the phage
(maintained at 4 °C as a concentrated suspension), duplicate serial di-
lutions (1 × 10−1–1 × 10−10) (total volume of 1000 μL) in sterile
phage buﬀer (PB) were duly prepared. To test tubes containing 4 mL LB
top agar (maintained at 40 °C), 300 μL of a 1:10 dilution of the bacterial
suspension in LB-broth were added together with 1000 μL of a given
phage dilution. The resulting mixture was gently shaken, immediately
poured and spread on top of Petri plates containing 25 mL solid Luria-
Bertani agar, which were then incubated overnight at 37 °C.
Puriﬁcation of the bacteriophage. After the incubation period, all
Petri plates were visually inspected for the presence of plaque forming
units (PFU) and, for those where complete lysis of the bacterial lawn
occurred or where PFU's were visible, 3 mL PB solution were added to
each Petri plate, after which they were isolated with Paraﬁlm™ (to
prevent them from drying out) and further incubated at room tem-
perature during 3 h. Following this time period, the layer of top agar
was fragmented by gently swirling a sterile loop, and the mixture of PB
and top agar was collected into a sterile 50-mL Falcon tube. Cell debris
and agar were then removed by centrifugation (5500 rpm, 15 min at
4 °C), and the supernatant carefully collected, ﬁltered under vacuum
through a sterilizing Stericup™-GP device (equipped with a PES mem-
brane with 0.22 μm pore diameter), and stored at 4 °C until use was in
order.
Determination of bacteriophage titer. For determination of phage
concentration in the stock-suspension, the propagation procedure was
repeated, with small diﬀerences, namely the plating of a top agar layer
containing 100 μL of a given serial dilution of the phage stock-sus-
pension in PB and 300 μL of the bacterial suspension. This procedure
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was carried out in triplicate, with each plate being incubated during
24 h at a diﬀerent temperature, viz. 30 °C, 37 °C and 25 °C, so as to
verify the optimum temperature for the bacterial phage infection.
Following incubation, the plates were visually inspected for the pre-
sence of plaques and the number of plaque-forming units (PFU's) was
duly counted in each bacterial lawn, after which the following equation
was applied (Table 1):
= ×
×
Phage particle concentration(PFU/mL) Number of PFU's 1
Dilution
1
V (mL)inoculum
2.2.2. Preparation of a W/O/W ME housing bacteriophage particles
The process for producing the W/O/W multiple emulsions (ME)
housing phage particles was carried out pursuing the methodology
described in detail by Glasser et al. [8,31]. The general compositions of
the W/O/W ME formulations produced are displayed in Table 2.
2.2.3. Determination of the encapsulation eﬃciency
For determination of the encapsulation eﬃciency, a spectro-
photometric assay was developed to quantify the phage particles in
suspension before and after the process of ME production. Departing
from the phage titer calculated from microbiological procedures, ﬁve
dilutions in ultrapure water (up to a total volume of 5.0 mL) using
diﬀerent volumes of the concentrated phage suspension (PS) produced
were prepared, and absorbance of the resulting dilutions was de-
termined at both 255 nm (producing the maximum absorption of the
concentrated PS) and 320 nm (where there is little light absorption
from phage chromophores) (Table 3). Subtracting A320 is meant to
correct crudely for light scattering from phage particles and non-phage
particulate contaminants.
Performing a linear ﬁtting to the data displayed in Table 3, the
equation Abs255nm-Abs320nm = 8.3487 × 10−9-0.5696 (r2 = 0.99887)
was obtained, and applying the equation of Beer-Lambert to the data
allowed one to obtain the molar extinction coeﬃcient of phage JG004
(whole) particles as ε= 8.3487 × 10−09 (PFU's/mL)−1 Cm−1, and
writing a formula for calculating the physical phage particle con-
centrations:
= ⋅
×
Phage particle concentration virions mLAbs -Abs
8.3487 10
-1@255nm @320nm
-9 . This
equation was then applied to calculate the concentration of phage
particles (virions/mL) in the ME supernatant following centrifugation
at 12500 rpm during 10 min at 4 °C. For these determinations, 2 mL-
aliquots of ME were poured into Eppendorf tubes and centrifuged at
12500 rpm during 10 min at 4 °C. Following centrifugation, 200 μL of
the supernatant were carefully collected, diluted to 2000 μL with ul-
trapure water, poured into a quartz cuvette and the absorbance read at
255 nm and 320 nm. For auto-zeroing the spectrophotometer at both
wavelengths, a placebo ME was utilized. The eﬃciency of encapsulation
(EE, %) was then determined as = ×EE(%) 100i-si , where i is the
number of phage virions oﬀered initially to prepare the ME and con-
tained in 2-mL of the ME, and s is the number of phage virions in the
supernatant of the 2-mL aliquot following centrifugation.
2.2.4. Determination of HS, PI and ZP
For (triplicate) determination of HS, PI and ZP of the aqueous-core
lipid nanodroplets by dynamic laser light scattering (DLS), the proce-
dure described by Glasser et al. [8] was pursued, using 1:400 dilutions
of ME samples in ultrapure water.
2.2.5. Fourier transform InfraRed spectrophotometry (FTIR) analyses
Infrared spectra were produced in the wavenumber range from
4000 cm−1 to 400 cm−1, with a resolution of 4 cm−1 and using Happ-
Genzel apodization.
2.2.6. X-ray diﬀraction (XRD) analyses
X-ray diﬀractograms were produced using X-ray radiation ﬁltered
through a Cu target. The X-ray scanning was performed at diﬀraction
angles of 2-Theta (from 5° to 90°, with increments of 0.02 ° and rate of
2°.min−1), with a voltage of 40 kV, electric current of 30 mA, and X-ray
power of 3 kW.
2.2.7. Nanoparticle tracking analysis (NTA)
The system comprised a green-light laser beam at 532 nm and a
sCMOS high-resolution camera, to perform the NTA at 25 °C. ME
samples were diluted 5000 x (1 μL sample in 4999 μL ultrapure water)
Table 1
Microbiological data gathered from the PFU determination assays, allowing determina-
tion of the phage titer of concentrated bacteriophage suspension.
Temperature (°C) Number
of PFUs
Dilution Volume of
inoculum
(mL)
Phage particle
concentration (PFU/
mL)
37 28 1.0 × 10−7 0.100 2.80 × 109
30 31 1.0 × 10−7 0.100 3.10 × 109
30 253 1.0 × 10−6 0.100 2.53 × 109
25 35 1.0 × 10−7 0.100 3.50 × 109
PFU's/mL ± σ (2.98 ± 0.42) x 109
Table 2
Composition of the W/O/W multiple emulsions (ME) housing bacteriophage particles (%, w/w).
Components Function in the
formulation
% (w/w)
ME10 ME1000 MEPLC
Internal aqueous
phase (Win)
Concentrated bacteriophage
suspension
Active antibacterial
agent
0.02 (10 μL of concentrated
phage suspension)
2.00 (1000 μL of
concentrated phage
suspension)
2.00 (1000 μL of a mixture of LB-
top agar (4 mL) and phage-buﬀer
(3 mL))
1.575 × 107 virions 1.575 × 109 virions 0 virions
Tween 80 Non-ionic 0.02 0.02 0.02
HCl 20 mM Electrolyte 1.96 – –
HCl 1000 mM – 0.04 0.04
Oily phase (O) Softisan100™ Lipid 1.00 1.00 1.00
Soybean phosphatidylcholine Lipophilic surfactant 0.75 0.75 0.75
Glycerol Protector, co-
surfactant
12.60 12.60 12.60
External aqueous
phase (Wext)
Poloxamer P188 Hydrophilic
surfactant
0.50 0.50 0.50
Methylparaben Preservative,
antifungal
0.10 0.10 0.10
Ultrapure water Diluent 83.05 82.99 82.99
TOTAL 100.00 100.00 100.00
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before performing the NTA analyses.
2.2.8. Thermal analyses via thermogravimetry (TGA) and diﬀerential
scanning calorimetry (DSC)
Thermal characterization followed the procedure described by
Glasser et al. [8], using 19–34 mg for the TGA analyses and 21–26 mg
for the DSC analyses.
2.2.9. Antimicrobial (lytic) activity of the W/O/W multiple emulsions
housing bacteriophage particles
MEs housing phage particles were subjected to testing for lysis halos
following application of samples of ME on a bacterial lawn of P. aeru-
ginosa. For extration of the phage particles, 500 μL chloroform were
added to 1000 μL ME housing phage particles in a test tube. The re-
sulting suspension was gently shaken in a vortex during 5 s and cen-
trifuged at 5500 rpm (10 min, 4 °C). Following centrifugation, the su-
pernatant was immediately recovered and subjected to antimicrobial
testing. This procedure was also repeated for the MEPLC. Into a test
tube containing 3 mL LB-top agar, 100 μL bacterial suspension (P. aer-
uginosa grown at 37 °C during 18 h in LB broth) were added. After mild
stirring, this suspension was poured into a Petri plate previously pre-
pared with LB-bottom agar, and allowed to solidify at room tempera-
ture. Each Petri plate was divided into four quadrants and the samples
were added according to two methods: (i) disk test, where a sterile ﬁlter
disk was placed in the centre of each quadrant and on top of each disk
one applied, separately, 20 μL of supernatant sample containing phages
recovered previously from the ME housing phage particles, 20 μL of
supernatant sample obtained from the placebo ME, 10 μL of the con-
centrated stock-PS (positive control) and 10 μL of the placebo of the
stock PS (negative control); (ii) droplet test, where a small droplet was
applied in the centre of each quadrant, directly on top of the solid LB-
bottom agar, separately, 20 μL of supernatant sample containing phages
recovered previously from the ME housing phage particles, 20 μL of
supernatant sample obtained from the placebo ME, 10 μL of the con-
centrated stock-PS (positive control) and 10 μL of the placebo of the
stock PS (negative control). The Petri plates were incubated at 37 °C
during 24 h, after which they were visually inspected for the presence
of lysis halos. To test wether chloroform exerted any deleterious action
upon the phage particles, during the extraction process from the ME,
another test was also performed exclusively for the (a) ME1000, and (b)
MEPLC systems, with and without phage particle extraction using
chloroform, using the aforementioned disk test approach.
2.2.10. (Cryo-/NS-) transmission electron microscopy analyses
Carbon grids were prepared using undiluted as well as diluted (1:5,
in ultrapure water) samples of ME1000, MEPLC and concentrated PS.
For the Negative Staining (NS), samples were prepared exactly in the
same way as described by Glasser et al. [8]. For cryo-freezing in
amorphous ice, the samples were prepared in Lacey Carbon Type A
300 mesh copper grids (Ted Pella Inc., Redding CA, U.S.A.), which were
previously submitted to a Glow Discharge process in an easiGlow device
(PELCO, Redding CA, U.S.A.) (electric current of 15 mA, negative
charge, 25 s discharge). Freezing in amorphous ice (cryo-preparation)
was carried out using a Vitrobot Mark IV equipment (FEI, Eindhoven,
The Netherlands) with controlled temperature (22 °C) and relative
humidity (100%). For preparing the cryo-samples, 3 μL of the samples
were dropped on the grids and allowed to settle for 20 s. The grids were
then blotted for 3 s and vitriﬁed by rapidly plunging into liquid ethane
at −145 °C, after which the grids were kept in liquid nitrogen at
−196 °C until the moment of analysis in the microscope, and main-
tained at −173 °C in the chamber of the microscope during the whole
analysis timeframe. Pure ME1000 samples were also prepared simply
by pouring tiny (3 μL) droplets directly on top of carbon grids (not
subjected to the Glow Discharge procedure), without any type of treat-
ment or staining, followed by removal of the excess sample using ﬁlter
paper, allowing to dry ﬁrst at room temperature during 1 h, and sub-
sequently in a vacuum chamber at room temperature during 7 days,
prior to carrying out TEM analyses. The electron microscope analyses
were then carried out as described by Glasser et al. [8].
2.2.11. Determination of the cytotoxicity potential of the W/O/W ME
systems, via the MTT assay
For cell proliferation, DMEM supplemented with bovine fetal serum
(10%, w/w) and antibiotic (100 UIpenicillin/mL plus
100 μLstreptomycin sulfate) (1%, w/w) was used, at pH 7.4 and 37 °C, under
a humid atmosphere containing 5% CO2. Upon reaching conﬂuence, the
cells (V79 and A549) were disadhered by using trypsin. Plating out was
performed by inoculating ca. 1 × 104 viable cells in each well of a 96-
well microplate, using 100 μL sample, followed by incubation for 48 h
until semi-conﬂuence was reached. Cell viability analysis using MTT
began with plating of a cell suspension containing 0.5 × 105 cells/mL.
After 24 h (time needed for cell adherence and stability) the cells were
placed in contact with the samples (ME10, ME1000, MEPLC, and PS
and its placebo) for an extra 24 h, in volume concentrations from 0 to
17.5% (v/v). The plates were then kept for 24 h in a heating cabinet set
at 37 °C with 5% CO2. After this step, the samples were washed away
with sterile PBS buﬀer and the cells exposed to MTT (0.5 mg/mL).
Cellular viability was determined using reduction of MTT. After 3 h at
37 °C and 5% CO2, the number of viable cells was determined by
measuring the amount of MTT converted to formazan (a purple com-
pound) by the mitochondrial dehydrogenases. For this, 100 μL DMSO
were added to each well and absorbance readings performed at 570 nm
in an ELISA microplate reader. All tests were performed in quintupli-
cate for each concentration of sample tested. The analysis of results was
carried out assuming as 100% of cell viability the average of the ab-
sorbance values obtained for the untreated control.
2.2.12. Determination of the apoptosis and necrosis potential of the W/O/
W ME systems, via image cytometry (Tali® analysis)
The cells that had been treated with diluted samples (concentrated
PS, MEPLC, ME10 and ME1000) at a concentration of 10% of that of the
departing samples, during 24 h, were centrifuged and concentrated to
1 × 106 cells/mL. 100 μL-aliquots of this cell suspension were prepared
according to the speciﬁcations of the Tali® Apoptosis Kit, and tests
performed in triplicate. After treatment, the content was transferred to
2 mL-test tubes, centrifuged at 1500 rpm for 5 min, and the resulting
supernatant discarded. The remaining material was resuspended with
100 μL Annexin binding buﬀer (ABB), 5 μL Annexin V Alexa Fluor® 488
were added, and the contents maintained in the dark at room tem-
perature during 20 min. After this period, the material was centrifuged
Table 3
Data utilized to prepare a calibration curve aiming at determining the molar extinction coeﬃcient of bacteriophage JG004 (whole) particles.
Sample volume of concentrated
bacteriophage suspension (μL)
Final volume of
dilution (mL)
Number of PFU's in the sample volume of
concentrated bacteriophage suspension
Phage particle
concentration (PFUs/mL)
Abs255nm Abs320nm Abs255nm-
Abs320nm
150.00 5.00 4.47 × 108 8.95 × 107 0.2450 0.0510 0.1940
200.00 5.00 5.97 × 108 1.19 × 108 0.5230 0.1080 0.4150
250.00 5.00 7.46 × 108 1.49 × 108 0.8840 0.1830 0.7010
300.00 5.00 8.95 × 108 1.79 × 108 1.1800 0.2430 0.9370
350.00 5.00 1.04 × 109 2.09 × 108 1.5040 0.3140 1.1900
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at 1500 rpm for 5 min, the supernatant was removed and 100 μL of
Annexin binding buﬀer (ABB) and 1 μL of Tali™ Propidium Iodide (PI)
were added, with the resulting solution being left standing for 5 min at
room temperature. The resulting material (25 μL) was placed in a
speciﬁc glass slide for reading, and viability, apoptosis and necrosis
were evaluated. Relative indexes of necrosis and apoptosis of the
treated groups (samples) were measured by considering the ratio of the
values of necrosis and apoptosis of the treated groups relative to the
negative control group.
2.2.13. Formulation of isotonic solutions (IS) integrating the W/O/W
ME1000 system, aiming at administration via nebulization, and
assessment of their antibacterial activity
Either 30 μL, 60 μL or 90 μL of ME1000 were added to 10 mL sterile
saline solution at 0.9% (w/v) NaCl in ultrapure water in separate
(sterilized) Falcon ﬂasks and duly homogenized via gentle shaking. For
determination of the antibacterial potential of these ISs, either 500 μL
or 1000 μL were poured into a test tube containing 4 mL top agar and
300 μL bacterial suspension (P. aeruginosa grown at 37 °C during 18 h in
LB broth). After mild stirring, the top agar containing the bacterial
suspension and the added IS was poured into a Petri plate, previously
prepared with 25 mL LB-bottom agar, and allowed to solidify at room
temperature. The Petri plates were then incubated at 37 °C during 24 h
and, following the incubation period, they were visually inspected for
the presence of lysis halos.
2.2.14. Determination of the DNA damage potential of the IS integrating the
W/O/W ME1000 system, via the comet™ assay
Each treatment group involved 10 μL of cells (V79-4, A549, and 3T3
ﬁbroblasts) in 110 μL of low melting point agarose (0.6%, w/v), with
the mixtures being placed onto microscope slides that had been pre-
coated with normal melting point agarose (1.5%, w/v). Coverslips were
positioned over the samples in the microscope slides, and the slides
were placed at 4 °C for polymerization to occur. Following poly-
merization, coverslips were removed and the slides treated with an ice-
cold (4 °C) lysis solution during 60 min. The treatment groups were
then incubated in an electrophoresis buﬀer (pH 13) during 20 min,
followed by electrophoretic analysis for 20 min at 1.3 V/cm. After
electrophoresis, the slides were covered with a neutralizing solution for
5 min, washed three times with distilled water, and allowed to stand
overnight at room temperature. Prior to staining, the dry slides were
left in a ﬁxing solution for 10 min, after which they were further wa-
shed three times with ultrapure water. Following these procedures, the
slides were allowed to stand at room temperature for 1.5 h, after which
they were rehydrated with ultrapure water and stained for approxi-
mately 15 min with a silver staining solution. Subsequently, the slides
were bathed in ultrapure water and then in a stop solution (acetic acid,
1% (v/v)). Finally, the slides were again gently washed with ultrapure
water and allowed to dry at room temperature. Silver staining is ana-
logous to ﬂuorescence, during which the positive charge of the silver
cations enables them to bind to DNA and DNA fragments, producing the
characteristic color. Analyses were performed using a Zeiss Axiovert-60
optical microscope, and at least 100 cells were counted on each slide,
with 3 slides for each test (ca. 300 cells). The analyses were carried out
in triplicate, totaling 900 cells for the analysis of each IS tested. The
Comet assay analyses were performed by assigning a score from 0 to 4
[42]. For this visual method, the number of cells found for each score
was multiplied by the value of the score; all the values were summed at
the end of the analysis of each slide. Because the score depended on the
number of cells observed, an index of tail damage (or DNA damage) was
created by normalizing the score given to the slide by the number of
cells analyzed on the slide.
3. Results and discussion
3.1. Propagation, puriﬁcation and quantiﬁcation of bacteriophage JG004
Propagation of the phage particles in the stock-suspension in its
speciﬁc host (P. aeruginosa) (Fig. 1a–j) resulted in a concentrated PS,
and was followed by determination of the phage titer.
Plating serial decimal dilutions of this concentrated PS, as described
in Section 2.2.1, allowed determination of the number of plaque-
forming units (PFUs) (Fig. 1k–o) for selected serial dilutions. It is pos-
sible to observe the formation of a phage lawn for the smaller dilutions,
up to 1 × 10−5, indicating a complete propagation of the phage and
concomitant lysis of all bacterial cells (Fig. 1a–j). Each plaque of lysis
corresponds to one unit of phage. Incubation of the bacteria with the
phage at three diﬀerent temperatures (30 °C, 37 °C and 25 °C) did not
show any diﬀerence in phage proliferation (Figs. 1k-o), thus providing
indication that both phage and bacteria demonstrate a similar activity
within this range of temperatures (Fig. 1k–o). An average phage par-
ticle concentration of (2.983 ± 0.416)x109 virions/mL (Fig. 1k–o) was
thus obtained for the concentrated PS following propagation of the
stock-suspension. A minimum absorption could be observed around
245 nm; when this minimum is absent from the spectrum, many con-
taminants are likely present in the suspension which often happens
Fig. 1. Results from phage JG004 propagation trials
in its Pseudomonas aeruginosa host, showing the for-
mation of plaque forming units (PFUs) for the whole
range of serial dilutions of the stock-solution of
bacteriophage JG004: (a) 10−1, (b) 10−2, (c) 10−3,
(d) 10−4, (e) 10−5, (f) 10−6, (g) 10−7, (h) 10−8, (i)
10−9, (j) 10−10; The microbiological quantiﬁcation
of the titer of bacteriophage concentrated suspension
is displayed in ﬁgures k-o: (k) 10−5, 30 °C, > 300
PFUs; (l) 10−6, 30 °C, 253 PFUs; (m) 10−7, 30 °C, 31
PFUs; (n) 10−7, 37 °C, 28 PFUs; (o) 10−7, 25 °C, 35
PFUs.
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when its contains fewer virions. This was not the case, however, with
the concentrated PS produced. Performing a linear ﬁtting to the data
displayed in Table 3, and applying the equation of Beer-Lambert to the
data allowed calculation of the molar extinction coeﬃcient of phage
JG004 (whole) particles as ε= 8.3487 × 10−09 (PFU's/mL)−1 Cm−1.
The physical phage particle concentration in the concentrated PS was
then calculated as 1.575 × 109 virions/mL, as described in Section
2.2.3. The concentration of phage particles obtained from spectro-
photometric readings was thus of the same order of magnitude but ca.
47% lower than that obtained from microbiological procedures. Taking
into consideration the large amount of physical phage particles in the
concentrated suspension, the results obtained from spectrophotometric
readings are suitable, e.g. for the quantiﬁcation of the encapsulation
eﬃciency, since a ratio of values calculated from this procedure will
virtually eliminate any error of the determination.
3.2. HS, PI and ZP
A previous work on the statistical optimization of the formulation
parameters leading to production of a stable W/O/W ME [31], fol-
lowing an experimental full factorial design, has set as mandatory
variables high levels of protein entity and lipophilic surfactant (viz.
lecithin) and a low level of hydrophilic surfactant (viz. poloxamer
P188), and a high-homogenization stirring speed. Following this set of
(optimized) processing parameters, three W/O/W ME were produced
(Table 2), viz. ME10, ME1000, and MEPLC. The results obtained from
the analysis by DLS of the several W/O/W ME are displayed in Fig. 2.
A larger amount of physical phage particles did not lead to any
changes in ZP values (Fig. 2c), but enhanced the antibacterial proper-
ties of the ME (as will be discussed in Section 3.8). The easiest way to
stabilize the system is to reduce surface tension, so as to decrease the
free energy derived from the expansion of the overall surface area [43].
Thus, we opted to increase the lipophilic surfactant level in producing
the ME, since tensioactive agents do play an important role in stabi-
lizing emulsions. However, most surfactants cannot reduce the inter-
facial tension to levels enough to counteract all the surface free energy
caused by the tremendous increase in surface area during homo-
genization, and thus emulsions are usually considered thermo-
dynamically unstable systems [40,44,45]. As can be seen in Fig. 2,
production of ME10 and ME1000 systems led to quite homogeneous
particles. Storage of these ME systems with encapsulated phage parti-
cles (Fig. 2) throughout nearly one year at 4 °C led to maintenance of
the particle HS between 159 and 165 nm (ME10) and between 176 and
189 nm (ME1000) (Fig. 2a), to a small increase of the PI during the ﬁrst
seven days (Fig. 2b), and to a small increase in the values of ZP during
the ﬁrst seven days presumably due to ion concentration at lipid na-
nodroplets interface (Fig. 2c). A placebo ME was also produced, without
encapsulated phage particles, and stored for nearly one year under the
same conditions; for this, the very same trend was found for the average
particle HS, together with a slight increase in ZP values. Increasing
molecular weight (as in Softisan 100™, with C10eC18 fatty acid moi-
eties) and decreasing dielectric constant (as in Tween 80) indicates a
greater hydrophobicity, leading to a greater impregnation of the in-
terface and to a more stable ME [8,32,46], which is in clear agreement
with the stability observed for our ME systems, both in terms of
maintenance of average particle HS and PI, and ZP values. The superior
stability of emulsions containing Tween 80 can be linked to the fact that
Tween 80 possesses an oleate-chain and one unsaturated bond, which
leads to a more stable O/W interface layer and subsequently to higher
emulsion stability [40]. The higher hydrophobicity of our ME systems is
further supported by the (calculated) weighted HLB average value
(13.418). To produce this value of HLB, the weighted HLB expression
by Schmidts et al. [40] was duly applied [8].
Fig. 2. Time evolution of average (n = 3) and associated σ of (a) HS, (b) PI, (c) ZP and
(d) pH of lipid nanodroplets encasing phage particle moieties, integrating the ME sys-
tems, throughout storage time (light blue circles, ME10; pink circles, ME1000; gray cir-
cles, MEPLC). (For interpretation of the references to colour in this ﬁgure legend, the
reader is referred to the web version of this article.)
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3.3. Encapsulation eﬃciency
Following centrifugation of 2-mL aliquots of both ME1000 and
MEPLC, 200 μL of ME1000 supernatant were carefully collected, di-
luted to 2000 μL with ultrapure water and the absorbance read at
255 nm and 320 nm using quartz cuvettes, using MEPLC as blank at
both wavelengths. Using this same approach for the concentrated PS,
with 40 μL supernatant diluted to 2000 μL with ultrapure water (i.e.
1:50 dilution), where a blank was prepared using a mixture of LB-top
agar (4 mL) and phage-buﬀer (3 mL) to auto-zeroing the spectro-
photometer at both wavelengths producing Abs255nm-
Abs320nm = 0.263, a concentration of phage particles in the con-
centrated PS was calculated as 1.575 × 109 virions/mL, as described in
Section 2.2.3. Using the results obtained from absorbance readings
(Abs255nm-Abs320nm = 0.142) with the supernatant of ME1000, a phage
particle concentration of 1.701 × 108 virions/mL was obtained for
ME1000 supernatant. Using the equation displayed in Section 2.2.3,
where the amount of virions oﬀered to prepare 2 mL of ME1000 was
equal to 3.150 × 109 virions and the amount of virions in the super-
natant of 2 mL of ME1000 was equal to 3.402 × 108 virions, the phage
particle encapsulation eﬃciency (EE) of ME1000 was EE = 89.2%. This
EE is related solely to phage virions, since absorbance readings were
made so as to exclude cell debris and any other intracytoplasmatic
proteins released upon bacterial cell lysis.
3.4. FTIR analyses
Fig. 3 displays the infrared spectra of MEPLC (Fig. 3d), ME10
(Fig. 3e), ME1000 (Fig. 3f), and concentrated PS (Fig. 3g).
The intensity peaks at wavenumbers 3300 cm−1 (MEPLC, Fig. 3d),
3300 cm−1 (ME10, Fig. 3e), 3350 cm−1 (ME1000, Fig. 3f) and
3250 cm−1 (concentrated PS, Fig. 3g) are characteristic of−OH group
stretching and indicate the presence of bonding with water molecules.
These peaks are more intense in Fig. 3d–f due to the aqueous nature of
the ME produced. In Fig. 3d–f one can observe peaks between 2853 and
2924 cm−1 (characteristic of sp3 CH stretches), 1746 cm−1 (Fig. 3d)
and 1742 cm−1 (Fig. 3e and f), characteristic of C]O stretch (dimer, H-
bonded), and in Fig. 3g a peak at 1600 cm−1, characteristic of eC]O.
In the infrared spectrum of the concentrated PS (Fig. 3g), a peak that
appears at 2931 cm−1 is probably attributable to CH2 asymmetrical
stretch, a peak that appears at 1525 cm−1 is probably attributable to
the angular deformation of a −NH2 group (either the terminal amine
group or an amine group of lysin moieties in the capsular or tail ﬁber
protein entities), a peak appearing at 1399 cm−1 is probably attribu-
table to a CeOeH in-plane bend, another peak appearing at 1457 cm−1
is most likely attributable to the −COO-, a peak appearing at
1067 cm−1 probably attributable to PO4, a peak appearing at 985 cm−1
is probably attributable to an out-of-plane OeH bend, and a peak ap-
pearing at 1243 cm−1 probably attributable to CeO stretch. Comparing
the infrared spectra of ME without (Fig. 3d) and with (Fig. 3e and f)
encapsulated phage particles, peaks are visible in the region from 1107
to 1030 cm−1, characteristics of eC]O bends. In the infrared spectra
of concentrated PS (Fig. 3g), a characteristic peak appears at
1067 cm−1 due to the stretching of the ePeOe bond in phosphate
groups. A comparison between the infrared spectra of ME without
(Fig. 3d) and with (Fig. 3e and f) encapsulated phage particles, may
lead to the conclusion that there are no displacement of major peaks,
neither the existence of the characteristic peaks of the infrared spec-
trum of free phage particles (1525 cm−1, 1399 cm−1, 620 cm−1 and
533 cm−1 (this last one probably attributable to CeC bends)), which
indicates that nearly all phage particles oﬀered in the preparation of
ME10 and ME1000 were in fact encapsulated, being therefore virtually
absent in the external aqueous phase of the ME. Additionally, com-
paring the infrared spectra of ME with encapsulated phage particles
(Fig. 3e and 3f), a characteristic peak at 1107 cm−1 (Fig. 3e) and
1101 cm−1 (Fig. 3f) with a higher intensity in Fig. 3f, further indicates
the presence of higher amounts of phage particles in the later.
3.5. XRD analyses
The results obtained from the X-ray diﬀraction analyses performed
to the concentrated PS and to MEPLC and ME1000 are displayed in
Fig. 4 as normalized diﬀractograms.
Since the intensity of peaks in the X-ray diﬀraction patterns also
depends on the concentration of bioactive entity, an increase in both
the intensity of peaks and diﬀraction pattern was expected for ME10
and ME1000 (Fig. 4 and zoomed insertion) relative to MEPLC (zoomed
Fig. 3. FTIR spectra of samples of (a) lecithin, (b) poloxamer 188, (c) Softisan100™, (d)
MEPLC, (e) ME10, (f) ME1000, and (g) concentrated bacteriophage suspension.
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insertion in Fig. 4). The diﬀractograms of MEPLC, ME10 and ME1000
exhibited a wide noisy band, with deﬁned peaks in the region of
18.00≤ 2Theta≤ 25.00, where the smaller and well-deﬁned peaks
produced indicate crystalline residues of the lipid (Softisan 100™) uti-
lized in the preparation of the ME. In particular, the X-ray diﬀracto-
grams revealed the presence of two signals, one at 2θ= 21.50° and
another at 2θ= 23.26° (MEPLC, ME10 and ME1000, zoomed insertion
in Fig. 4), which are both characteristic of the orthorhombic poly-
morphic form frequently observed in complex triacylglycerols such as
Softisan 100™ [47]. Subtraction of MEPLC diﬀractogram from ME1000
diﬀractogram (i.e. ME1000-MEPLC) allowed cancellation of the eﬀect
of the lipid matrix integrating the aqueous-core nanodroplets and
clearly does not show peaks that stand out on the curve. This allows to
conclude that the amount of phage particles in the external aqueous
phase was too small to absorb energy from the X-rays hitting the
sample, and thus observe the amorphous character of the lipid nano-
droplets housing phage particles. This conclusion is in fact supported by
the shallow peak observed in curve ME1000-MEPLC in the region of
19.00≤ 2Theta≤ 40.00 (Fig. 4).
3.6. NTA analyses
The samples (1 μL sample previously diluted in 4999 μL ultrapure
water) were hit by a green-light laser beam at 532 nm and the Brownian
motions of the lipid nanodroplets were captured by a sCMOS high-re-
solution camera, to perform NTA, allowing to observe the absence of
aggregation phenomena. This analysis (performed in quintuplicate)
allowed one to calculate the diﬀusion coeﬃcient of the lipid nano-
droplets integrating ME1000. Particle concentration in the ME was
determined as 2.39 × 1012 particles/mL, with a dynamic viscosity of
η= 0.888704 cP (or 0.000888704 kg/(m.s)). Assuming a homo-
geneous hydrodynamic particle diameter for the lipid nanodroplets in
ME1000 of 188.54 nm, the diﬀusion coeﬃcient of the lipid nano-
droplets housing phage particles could be calculated using the Stokes-
Einstein equation, viz. =D k ·T6·π·η·r
B , where D is the diﬀusion coeﬃcient, kB
is the Boltzmann’s constant (1.3806488 × 10−23 m2 kg/(s2 K)), T is the
absolute temperature (K), η is the dynamic viscosity (kg/(m.s)), and r is
the hydrodynamic radius (m) of a spherical particle. The diﬀusion
coeﬃcient of the lipid nanodroplets integrating ME1000 was calculated
as 2.607 × 10−12 m2 s−1. Most notably, this result is comparable and
of the same order of magnitude (10−12 m2 s−1) as the results published
by Glasser et al. [8] and Katayama et al. [48]. Diﬀusion coeﬃcients for
molecules fall usually in the range 10−10–10−7 m2 s−1, but diﬀusion
coeﬃcients for nanoparticles are typically of the order of magnitude of
10−12 m2 s−1 [48]. Lecithin has been reported to stabilize W/O/W ME
[40], with the increased stability being related to a change in the dif-
fusion coeﬃcient of water and water-soluble substances subject to the
oily-phase composition. ME stability is negatively correlated with the
diﬀusion coeﬃcient, with a higher stability being associated with a
lower diﬀusion coeﬃcient [40,48].
3.7. TGA and DSC analyses
A close inspection of the thermogravimetric curves (Fig. 5a) of W/
O/W ME systems, allows identiﬁcation of two major mass loss events,
attributable to water loss. The ﬁrst water loss event occurs from about
50 °C up to 110 °C, probably related to water loss from the external
aqueous phase. The second water loss event, extending from ca. 120 °C
up to 185 °C, is most likely linked to the loss of the lipid constituent of
the nanodroplets with concomitant water loss from the internal aqu-
eous phase. As expected, the thermogravimetric curve of the con-
centrated PS exhibited only one major mass loss event, entending from
about 50 °C up to 105 °C, due to the aqueous nature of the suspension
possessing only phage particles and bacterial cell debris. The 1 st
Fig. 4. X-ray diﬀractograms (XRD) of samples of lecithin (grey), poloxamer 188 (red), Softisan100™ (blue), MEPLC (black), ME1000 (green), and of the concentrated bacteriophage
suspension (purple). The diﬀractogram in the brown curve was produced by subtracting the normalized MEPLC diﬀractogram from that of ME1000. (For interpretation of the references
to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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derivative of the weight loss curve (i.e., the rate of mass change,
Fig. 5b) can be used to tell the points at which weight loss is most
apparent (inﬂection points), viz. 110 °C and 180 °C for MEPLC, 105 °C
and 180 °C for ME1000, 100 °C and 180 °C for ME10 and, once more as
expected, 100 °C for the concentrated PS. Being essentially inert entities
of proteic nature, phage particles are not hygroscopic in nature and thus
are not expected to adsorb more water molecules when imprisoned
within the aqueous core of the lipid nanodroplets, and in fact this can
be observed from a close inspection of Fig. 5a and b, where no dis-
placement in the thermogravimetric curves (Fig. 5a) could be observed
for MEPLC, ME10 and ME1000, with water loss from the inner core of
the lipid nanodroplets occurring at the same (higher) temperature most
probably due to hydrogen bonding between water molecules and
Tween 80. This can be conﬁrmed by inspection of Fig. 5b, where such
absence of displacement can be seen more clearly in the second peak.
ME1000 underwent a two-step weight loss process, and is stable at least
up to 50 °C. The TGA analysis of the nanodroplets showed a weight loss
of about 87.5% up to 120 °C which can be attributed to the loss of the
external water phase from the systems. The lipid nanodroplets matrix
system, however, showed a weight loss of about 10% when heated up to
200 °C as shown in Fig. 5a and b.
The results from DSC analyses are displayed in Fig. 5c–f. Im-
prisonment of phage particles within the aqueous-core lipid nano-
droplets promoted a slight decrease in the melting temperature peaks
(absorption peaks at 110.34 °C, 167.08 °C and 196.18 °C and associated
melting enthalpies of 1.429 J/mg, 0.2659 J/mg and 0 J/mg, respec-
tively, for MEPLC (Fig. 5c), to absorption peaks at ca. 108.21 °C,
152.44 °C and 191.22 °C and associated melting enthalpies of 1.518 J/
mg, 0.1170 J/mg and 0.0225 J/mg, respectively, for ME1000 (Fig. 5e)),
denoting a shortening of the melting temperature range in the case of
ME1000 (Fig. 5c and e). Inclusion of phage particles in the lipid na-
nodroplets led to a signiﬁcative decrease in the peak of heat absorption
(108.21 °C), when compared with that of the concentrated PS
(210.56 °C), due to amorphization of the system. The same trend was
noticed when comparing MEPLC and ME1000. When analyzing
ME1000, one obtained a melting enthalpy of 1.518 J/mgnanoemulsion, at
108.21 °C, a value only 6.23% higher than that of MEPLC, which
probably accounts for the stabilizing eﬀect of the nanoencapsulation
procedure. These results (Fig. 5c–f) are in close agreement with those
obtained from X-ray diﬀraction (Fig. 4), since as can be seen from in-
spection of the DSC thermograms, imprisonment of the phage particles
within the aqueous core lipid nanodroplets led to a decreased crystal-
linity with shortening of the melting proﬁle. Amorphization of the lipid
envelope upon imprisonment of the phage particles (Figs. 4 and 5 c–f)
most likely enhanced the accomodation capability of the lipid nano-
droplets for a macromolecule such as a phage particle. Due to decreased
rigidity, a reduction in the release rate of entrapped particles was most
likely certain, which in turn might explain the high stability observed
for the W/O/W ME system with entrapped phage particles (Fig. 2). A
close inspection of the DSC thermograms displayed in Fig. 5c–f allows
to observe three distinct endothermic events: one at 196.18 °C (MEPLC)
that moved to 191.22 °C (ME1000), implying a decrease in crystallinity;
one at 167.08 °C (MEPLC) that moved to 152.44 °C (ME1000); and one
at 110.34 °C (MEPLC) that moved to 108.21 °C (ME1000). Remarkably,
the thermal events depicted in Fig. 5c–f and the X-ray diﬀractograms
depicted in Fig. 4 denote a clear transition from a crystalline state of the
Fig. 5. Thermogravimetric curves (a) and 1st derivative of the weight loss curves (b) of concentrated PS (blue lines), MEPLC (pink lines), ME10 (gray lines), and ME1000 (green lines),
and DSC thermograms of (c) MEPLC (pink lines), (d) ME10 (gray lines), (e) ME1000 (green lines), and (f) concentrated PS (blue lines). (For interpretation of the references to colour in
this ﬁgure legend, the reader is referred to the web version of this article.)
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lipid nanodroplets (Fig. 5c, MEPLC) to a more amorphous counterpart
(Fig. 5e, ME1000), due to the imprisonment of the phage particles,
thereby leading to the increased stability observed for ME1000. Re-
garding the thermogram of the concentrated PS (Fig. 5f), the two peaks
appearing at 203.68 °C and 210.56 °C are most probably related to the
lipid nature of the bacterial cell debris present in the suspension. Most
notably, the thermogram produced for ME10 (Fig. 5d) exhibits only two
main heat absorption events, one at 140.30 °C and another at 175.18 °C.
Since this ME system was produced using a much smaller amount of
phage particles (i.e., 100 times less than that oﬀered in the preparation
of ME1000), the absence of the third peak (present at ca. 191.22 °C in
ME1000) was most likely related to the virtually nill amount of bac-
terial cell debris. Clearly, the widening of the melting proﬁle range by a
factor of 1.27 x (ΔT = 44.23 °C in ME1000; ΔT = 34.88 °C in ME10),
implies a decreased crystallinity of ME1000 due to amorphization of the
lipid envelope upon imprisonment of (one or more) phage particles.
3.8. Antibacterial activity of the W/O/W ME systems
The antibacterial activity of both ME10 and ME1000 was assessed in
vitro against a pathogenic strain of P. aeruginosa (Fig. 6).
As can be seen from inspection of Fig. 6a–e, the concentrated PS
demonstrated a very high lytic activity, as was expected (Fig. 6a–d,
lower left quadrants). However, ME10 failed to exhibit any anti-
bacterial activity (Fig. 6c and d, upper left quadrants). Several re-
searchers reported no loss of phage viability with homogenization
speeds up to 14,000 rpm [5]. But, after increasing the amount of phage
virions oﬀered by two orders of magnitude to 1.575 × 109 virions, the
resulting ME1000 system displayed a pronounced antibacterial activity
(Fig. 6a and b, upper left quadrants). MEPLC for ME10 and ME1000
were also produced and tested for antibacterial activity and, as ex-
pected, the results did not exhibit any antibacterial activity whatsoever
(Fig. 6a–d, upper right quadrants). To test whether the dilution medium
of the phage virions could somehow inhibit bacterial growth, a placebo
suspension was also prepared by mixing LB-top agar (4 mL) and phage-
buﬀer (3 mL), duly sterilized and tested in the same manner as the ME
systems and the concentrated PS. As expected, the results did not ex-
hibit any antibacterial activity whatsoever (Fig. 6a–d, lower right
quadrants). Additionally, and since the phage virions in ME10 and
ME1000 were extracted from the lipid nanodroplets with chloroform
prior to testing for antibacterial activity, the antibacterial potential of
ME1000 was compared when chloroform was used or not prior to
plating. Fig. 6e displays in the upper left quadrant the result obtained
for the ME1000 supernatant following extraction with chloroform and
centrifugation, in the upper right quadrant the result obtained for plain
ME1000, in the lower left quadrant the result obtained for the MEPLC
supernatant after extraction with chloroform and centrifugation, and in
the lower right quadrant the result obtained for the concentrated PS. As
can be seen, extraction of phage particles from the lipid nanodroplets
with chloroform did not exert any deleterious eﬀect upon their lytic
activity.
3.9. (Cryo-/NS-) TEM analyses
TEM analyses were performed with samples of concentrated PS and
ME1000 via two diﬀerent processes, viz. cryo-TEM and Negative-
Staining TEM (NS-TEM). The structure of the lipid nanodroplets in-
tegrating the ME1000 system is shown in Fig. 7e and f, but the NS-TEM
analysis was not able to distinguish phage particles within their inner
aqueous core.
The process of coloration of particles with uranyl acetate involves a
gentle air-drying of the sample following application of 3 μL of an
aqueous solution of uranyl acetate at 2% (w/w) on the copper grid
containing the sample. Although very gentle, such drying is suﬃcient to
promote a deformation of the particles, and in fact this can be clearly
observed in micrographs (d)–(i) in Fig. 7. On the contrary, TEM ana-
lyses following vitriﬁcation of the samples allows observation of par-
ticles as they really are, without any alterations in their shape, since the
samples are vitriﬁed with the particles suspended in a thin layer of
amorphous ice. Notwithstanding this fact, TEM analyses following
Fig. 6. Antimicrobial activity of ME1000 (a and b)
and ME10 (c and d). Upper left quadrant: 20 μL ME
applied on sterile ﬁlter paper disk (a and c) or a
20 μL-droplet of ME (b and d) applied directly on the
surface of LB top agar prepared with 100 μL bacterial
suspension of P. aeruginosa; Upper right quadrant:
20 μL MEPLC applied on sterile ﬁlter paper disk (a
and c) or a 20 μL-droplet of MEPLC (b and d); Lower
left quadrant: 10 μL concentrated bacteriophage
suspension applied on sterile ﬁlter paper disk (a and
c) or a 10 μL-droplet of concentrated bacteriophage
suspension (b and d); Lower right quadrant: 10 μL
sterile phage dilution medium applied on sterile
ﬁlter paper disk (a and c) or a 10 μL-droplet of sterile
phage dilution medium (b and d); (e) upper left
quadrant: 20 μL supernatant of ME1000 after ex-
traction with chloroform and centrifugation; upper
right quadrant: 20 μL ME1000; lower left quadrant:
20 μL of supernatant of MEPLC after extraction with
chloroform and centrifugation; lower right quadrant:
10 μL of concentrated bacteriophage suspension.
Figures f-k display results from antimicrobial activity
assays of ISs prepared with ME1000, using the anti-
microbial test of incorporation. Results from anti-
bacterial activity of 500 μL (f) and 1000 μL (g) IS
prepared with 0.3% (v/v) ME1000 upon a bacterial
lawn of P. aeruginosa, of 500 μL (h) and 1000 μL (i)
IS prepared with 0.6% (v/v) ME1000, and of 500 μL
(j) and 1000 μL (k) IS prepared with 0.9% (v/v)
ME1000. Inserted arrows pinpoint the lysis halos
produced by encapsulated (i) or free (ii) phage par-
ticles.
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negative-staining of the samples allows observation of the particles with
a greater contrast (e.g. micrographs (d)–(h) in Fig. 7). As voltage in-
creases, so does the electron energy and, as a consequence, the elec-
trons interact less with matter over a given thickness and therefore
produce less contrast, which is a crytical parameter in cryo-TEM [49].
This was indeed the case with our analyses, since the TEM utilized for
performing the analyses operated at 120 kV, an electron energy high
enough to produce images with not so great contrast. Also, in Cryo-TEM
analyses, particles are suspended in a layer of ice whose thickness may
be much larger than the particles themselves, which further contributes
to a poor contrast of the micrographs. This would more favorably be
dealt with by a higher voltage, which produces a larger depth of ﬁeld,
however it would promote melting of the ice layer and damage the
sample. Liquid ethane was used to vitrify our water-rich ME1000
samples for cryo-TEM, since a thin ﬁlm of water quickly immersed in
liquid ethane at−145 °C freezes too rapidly for water to crystallize and
thus becomes amorphous. This rapid freezing by plunging the samples
in liquid ethane does not disrupt the structure of both the phage par-
ticles and the soft aqueous-core lipid nanodroplets present in the liquid
state, as the formation of ice crystals can do. Hence, cryo-TEM analyses
allowed observation of particles in a near-native hydrated state since
the samples were vitriﬁed, keeping the particles suspended in a thin
Fig. 7. Cryo-TEM micrographs of the concentrated
PS, showing (a) the profusion of phage particles
suspended in a layer of ice occupying several of the
multitude of holes contained in the carbon grid used
to prepare the sample just to show the representa-
tiveness of the analysis, (b) several phage particles
attached to bacterial cell debris, (c) a detail of sev-
eral phage particles attached to cell debris allowing
to observe the tail ﬁbers and the hexagonal capsids
showing the presence (green arrow) and absence
(white arrow) of dsDNA, (g) a single phage particle
allowing to clearly observe the morphology of phage
JG004 with its characteristic hexagonal capsid and
tail ﬁbers (yellow arrow); NS-TEM micrographs of
(d) a phage particle, (e) and (f)ME1000, and (h) and
(i) phage particles allowing to clearly observe the
helical structure of its contractile sheath (pink ar-
rows). Photomicrographs (j) and (k) were produced
without any treatment of ME1000. (For interpreta-
tion of the references to colour in this ﬁgure legend,
the reader is referred to the web version of this ar-
ticle.)
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layer of amorphous ice. Nevertheless, micrographs (e) and (f) allows to
clearly observe the structure of the lipid nanodroplets integrating our
ME1000 system, as well as the total absence of aggregation phenomena.
Additionally, a careful inspection of TEM photomicrographs (e) e (f)
allows to observe the existence of a dark line surrounding each particle.
In fact, such line may correspond to an accumulation of the lipid sur-
factant (soybean lecithin) at the interface between lipid nanodroplets
and the external aqueous phase of the ME system, translating into a
higher concentration of carbon atoms at that same interface with con-
comitant higher opacity to penetration of electrons. Hence, the negative
charge of the lipid surfactant that most likely accumulated at that in-
terface may have contributed to the much negative ZP of the lipid na-
nodroplets housing phage particles in their inner aqueous core. In
photomicrographs (j) and (k) in Fig. 7, produced with non-treated
(pure) ME1000 samples, one can clearly observe the spherical shape of
the lipid nanodroplets although the images are rather diﬀuse due to the
thickness of the dried samples on the carbon grids. One can also observe
a phage particle in photomicrograph (j) (light-blue arrow), and the
higher density of carbon atoms in the phage particle (of protein nature)
might allow to suggest that the particle was in fact encapsulated within
the nanodroplet.
3.10. Determination of the cytotoxicity potential of the W/O/W ME
systems, via the MTT assay
The MTT assays show cell viability found after exposure to in-
creasing product concentrations (Fig. 8a), allowing to establish the half
maximal inhibitory concentration (IC50).
At the product concentrations tested in cells A549, both the con-
centrated PS and its placebo did not present a high toxicity, with these
cells presenting a viability of ca. 80% with a product concentration
around 10%. Regarding MEPLC, ME10 and ME1000, they all promoted
a drop in cell viability (IC50 values in Table 4).
From inspection of the data displayed in Table 4, one can observe
that cells A549 presented a higher resistance to the treatments with the
products, being necessary a higher concentration of product(s) to attain
50% of cell death. With cell line A549, treatment with products ME10
and ME1000 did not present signiﬁcative diﬀerences, whereas with cell
line V79 it was possible to verify a higher toxicity upon treatment with
product ME1000 (Table 4 and Fig. 8a).
3.11. Determination of the apoptosis and necrosis potential of the W/O/W
ME systems, via image cytometry (Tali® analysis)
The results obtained from the analysis of cell death type were
gathered using 10% of the concentration of the original products
(Fig. 9a). Although cells A549 presented a IC50 higher than that of cells
V79, when they were evaluated with a concentration at 10% of the
original products they presented a low index of viability, with the
majority of the cells dying from necrosis (Fig. 9a), except for the
treatment with product ME1000, which promoted cell death by apop-
tosis in a larger proportion. The treatments performed with cell line
V79 promoted a lower index of cell death, with the majority of cell
deaths occurring by apoptosis.
From the results displayed in Fig. 9a, one may conclude that the
products studied present a low cytoxicity when in concentrations below
10% of the original (stock) products, with the diﬀerent cell lines ap-
pearing to respond in a diﬀerentiated manner to the treatments. It must
also be considered that although the concentrated PS did not present
any toxicity, proving that its utilization is safe, and that the na-
noencapsulation procedure resulted in a product (ME1000) that seems
to promote cell suﬀering during the ﬁrst 24 h, it is necessary to verify if
cellular stability is recovered after this initial period of time through
new analyses of viability vs. time. The results from these analyses show
that cells treated with the products exhibited a lower cell viability,
presenting a total of cells less than that of the negative control. The cells
treated with the tested products presented a high index of apoptosis and
necrosis, which can be found mainly in the relative data displayed in
Fig. 9a. The results show that MEPLC, ME10 and ME1000 have an eﬀect
on cell viability, being possible to use them in concentrations below 4%
(ME10) or 1% (ME1000), as these were the IC50 concentrations for each
sample tested.
3.12. Antibacterial potential of the ISs integrating the ME1000 system
Due to the very low amounts of ME1000 added to the saline solu-
tion, the resulting mixtures were naturally already isotonic and suitable
for administration via nebulization. The results obtained for the anti-
bacterial properties of these ISs, formulated with ME1000, are dis-
played in Fig. 6f–k for diﬀerent volume concentrations, viz. 0.3% (v/v)
(f (500 μL) and g (1000 μL)), 0.6% (v/v) (h (500 μL) and i (1000 μL)),
and 0.9% (v/v) (j (500 μL) and k (1000 μL)). From inspection of
Fig. 6f–k (inserted arrows), diﬀerent patterns of lysis were produced
when phage particles were encapsulated (i) or remained in free form (ii)
in ME1000. Since the volume usually projected during a nebulization
jet is of the order of magnitude of 500 μL, and because (at least in
theory) a single phage particle would be suﬃcient to completely era-
dicate a bacterial infection, all the ISs tested would be highly eﬀective
in eradicating a lung bacterial infection by P. aeruginosa.
3.13. Determination of the cytotoxicity potential of the ISs integrating the
ME1000 system, via the MTT assay
The cellular viability data obtained upon exposure of the three cell
lines to the ISs prepared with ME1000 is displayed in Fig. 8b. When
testing the viability of concentrated ME1000, one noticed that con-
centrations between 0.3% to 0.9% (v/v) exhibited a good cell viability
for the diﬀerent cell lines, and so new saline solutions were prepared at
concentrations of 0.3%, 0.6% and 0.9% (v/v) so as to be tested re-
garding their eﬀects upon cell viability, either via MTT analyses or
image cytometry. For the MTT analyses, the (isotonic) saline solutions
were further diluted to 35%, 30%, 25%, 20%, 15%, 10%, 5% and 1%
(v/v) and, for the cell viability, necrosis and apoptosis the saline solu-
tions were always tested at a concentration of 30% (v/v). The results
obtained (Fig. 8b) show that, at this concentration, the diﬀerent cell
lines did not present cell death higher than 50%, with the cell type most
sensitive being V79 which, at a concentration of 35% (v/v) of the ISs,
displayed 50% of cell death.
3.14. Determination of the apoptosis and necrosis potential of the ISs
integrating the ME1000 system, via image cytometry (Tali® analysis)
The results gathered via image cytometry (Fig. 9b) clearly show
that, when tested at 30% (v/v) of the diﬀerent concentrations of the
isotonic saline solutions, the cells exhibited a high viability. It is pos-
sible to observe that the major part of cell death in line V79 occurs due
to necrosis and not due to induction by cell apoptosis, and in cell lines
3T3 and A549 it is possible to observe an equilibrium between the two
types of cell death (Fig. 9b). Based on the results obtained pertaining to
cell viability tests (both MTT and image cytometry), it is possible to
argue that the ISs tested exhibited a good cell viability, while displaying
a low cell toxicity.
3.15. Determination of the oxidative stress potential of the ISs integrating
the ME1000 system
The possible oxidative stress eﬀects of the ISs prepared with
ME1000 are displayed in Fig. 10 for the three cell lines evaluated, in the
form of relative stress indexes.
The oxidative stress tests revealed that cell treatments with all ISs
resulted in cell stress levels signiﬁcantly higher than that of the positive
control (Two-Way ANOVA at 5% signiﬁcance, with those results
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statistically diﬀerent from that of the control marked with '*'), existing a
slight variation among cell lines (Fig. 10). In general, an increase in the
oxidative stress reﬂects in higher cell apoptosis, which is possible to
verify when comparing the results obtained in the oxidative stress
analyses with the results from apoptosis/necrosis, allowing to clearly
observe an increase in the apoptosis of the cell line V79, mainly with
the IS at a concentration of 0.3% (v/v) (Fig. 10).
3.16. Determination of the DNA damage potential of the ISs integrating the
ME1000 system, via comet™ assay
To evaluate any possible genetic damage to the cells imparted by the
saline ISs integrating ME1000, the Comet™ test was carried out with lung cell
lines (V79 and A549), allowing to observe no signiﬁcant diﬀerences between
the control and the lung cell lines that were exposed to the ISs (Fig. 11).
Fig. 8. Results from cellular viability (MTT assays)
(a) using cell lines A549 and V79 cultured in DMEM
medium to evaluate the cytotoxicity of placebo of PS,
concentrated PS, MEPLC, ME10 and ME1000, during
a 24 h treatment period at diﬀerent concentrations,
and (b) using cell lines V79, 3T3 and A549 cultured
in DMEM medium to evaluate the cytotoxicity of ISs
prepared with ME1000, during a 24 h treatment
period at diﬀerent concentrations (means (n = 5),
with σ < 0.1).
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This means that the ISs tested do not possess characteristics that
promote lesions in the DNA. If one compares these results with the
results generated by both the oxidative stress analyses and apoptosis/
necrosis, it is possible to observe that lung cell lines V79 and A549 did
not exhibit a high apoptosis index, although signaling an increase in the
oxidative stress relative to that of the control. Fig. 11 represents the
genotoxic eﬀects (DNA damage index) of lung cell lines V79 and A549
incubated with ISs integrating variable amounts of ME1000. For A549
and V79 cell lines, the ISs integrating ME1000 showed no signiﬁcant
genotoxic eﬀects at the three tested concentrations (viz., 0.3%, 0.6%
and 0.9%, v/v). These results are in clear agreement with the lack of
cytotoxic eﬀects observed for both cell lines (Fig. 8b). Hence, the lack of
cytotoxic eﬀects is in line with the lack of DNA damage, which is in
clear agreement with results published elsewhere [42].
Table 4
Results obtained for the IC50 values via MTT assays with cell lines A549 and V79, ex-
posed to the concentrated bacteriophage suspension, to the placebo of the phage sus-
pension, and to W/O/W multiple emulsion systems MEPLC, ME10 and ME1000.
Cell line Product used in treatment IC50
A549 Concentrated bacteriophage suspension Not cytotoxic up to 17.5%
Placebo of the bacteriophage suspension Not cytotoxic up to 17.5%
MEPLC 4.55%
ME10 6.11%
ME1000 6.87%
V79 MEPLC 4.76%
ME10 4.23%
ME1000 3.38%
Fig. 9. Relative indexes of cell necrosis and apop-
tosis in (a) cell lines A549 and V79 following treat-
ment with the placebo of PS, the concentrated PS,
MEPLC, ME10 and ME1000, with concentrations set
at 10% of the initial values, and in (b) cell lines V79,
3T3 and A549, following treatment with the ISs
prepared with ME1000, with concentrations set at
30% of the initial values (means (n = 5), with
σ < 0.1).
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4. Conclusions
Imprisonment of phage particles in a nano-sized aqueous core pro-
motes a change in the thermodynamic conditions of the nanoenviron-
ment surrounding each phage particle due to the fact that the move-
ments of (aqueous) solvent molecules in their microneighborhood
become seriously reduced by the eﬀect of being contained within the
matrix’s aqueous core, thereby leading to enhanced thermodynamic
stability. The net result is a potentiation of the phage particle’s rota-
tional, translational and vibrational viscosity, promoting a more rigid
three-dimensional architecture of the particle with concomitant de-
crease of entropy and thus promoting its structural and functional
stabilization [3,4,8–10,32]. For A549 and V79 cell lines, the three ISs
integrating ME1000 showed no signiﬁcant genotoxic eﬀects, which was
in clear agreement with the lack of cytotoxic eﬀects observed for both
cell lines. The use of ME1000 in formulating an IS for nebulization in
the treatment of bacterial (P. aeruginosa) lung infections, would possess
inherent advantages, when compared with the current chemical anti-
biotherapy, in that speciﬁc and strictly lytic phages are natural self-
replicating predators of bacteria that continuously replicate at the site
of infection while there are still viable host cells, while being virtually
harmless to human cells and tissues.
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